Company / Financials
ESCALON MEDICAL CORP Financials
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$9.4M
FY2020 · -17.6% YoY
Net Income
-$650.3K
FY2020 · -211.4% YoY
Profit Margin
-6.9%
FY2020 · net income / revenue
ROE
-43.0%
FY2020 · return on equity
Total Assets
$5.7M
FY2020
Total Debt
-
FY2020
Equity
$1.5M
FY2020
ROA
-11.4%
FY2020 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -8.98 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$9.4M-17.6% YoYNet Income HistoryProfit after all expenses and taxes-$650.3K-211.4% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$5.2M-17.5% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$1.4M-783.7% YoYSG&A Expense HistorySelling, general, and administrative expenses$3.9M-11.9% YoYR&D Expense HistoryResearch and development spending$1.1M+124.3% YoYInterest Expense HistoryCost of borrowing and debt obligations$13.6K-89.2% YoYIncome Tax HistoryTotal income tax expense-EPS (Basic) HistoryBasic earnings per share-$0.04+60.0% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$0.04+60.0% YoY